EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Healthcare and Cancer Treatment Costs of Breast Screening Outcomes among Higher than Average Risk Women

Nicole Mittmann, Kristina M Blackmore iD, Soo Jin Seung, Christina Diong, Susan J Done, Anna M Chiarelli

Current Oncology · 18.09.2023 · 30 (9) · 8550-8562

DOI: 10.3390/curroncol30090620 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Current Oncology, online erschienen am 18.09.2023. Verfasst von Nicole Mittmann und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology & Toxicology, University of Toronto, 1 King's College Circle, Toronto, ON M5S 1A8, Canada. Hauptthemen laut MEDLINE: Early Detection of Cancer, Breast Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Canadian Cancer Society, ICES.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Concurrent cohorts of 644,932 women aged 50–74 screened annually due to family history, dense breasts or biennially in the Ontario Breast Screening Program (OBSP) from 2011–2014 were linked to provincial administrative datasets to determine health system resource utilization and costs. Age-adjusted mean and median total healthcare costs (2018 CAD) and incremental cost differences were calculated by screening outcome and compared by recommendation using regression models. Healthcare costs were compared overall and 1 year after a false positive (n = 46,081) screening mammogram and 2 years after a breast cancer diagnosis (n = 6011). Mean overall healthcare costs by age were highest for those 60–74, particularly with annual screening for family/personal history (CAD 5425; 95% CI: 5308 to 5557) compared to biennial. Although the mean incremental cost difference was higher (23.4%) by CAD 10,235 (95% CI: 6141 to 14,329) per breast cancer for women screened annually for density ≥ 75% compared to biennially, the cost difference was 12.0% lower (−CAD 461; 95% CI: −777 to −114) per false positive result. In contrast, for women screened annually for family/personal history, the mean cost difference per false positive was 19.7% higher than for biennially (CAD 758; 95% CI: 404 to 1118); however, the cost difference per breast cancer was only slightly higher (2.5%) by CAD 1093 (95% CI: −1337 to CAD 3760). Understanding that associated costs of annual compared to biennial screening may balance out by age and outcome can assist decision-making regarding the use of limited healthcare resources.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Early Detection of CancerBreast NeoplasmsFemaleHumansHealth Care CostsHealth ResourcesMammography

Stichwörter der Autor:innen

annual screeningbiennial screeningbreast cancerdigital mammographyfalse positivefamily historyhealthcare costsmammographic density

Autor:innen und Institutionen

  • Department of Pharmacology & Toxicology, University of Toronto, 1 King's College Circle, Toronto, ON M5S 1A8, Canada.
  • Sunnybrook Research Institute, Sunnybrook Health Sciences Centre, Toronto, ON M4G 3M5, Canada.
  • Ontario Health, 525 University Avenue, 5th Floor, Toronto, ON M5G 2L3, Canada.
  • HOPE Research Centre, Sunnybrook Research Institute, 2075 Bayview Avenue, Toronto, ON M4N 3M5, Canada.
  • ICES Central, 2075 Bayview Avenue, Toronto, ON M4N 3M5, Canada.
  • Laboratory Medicine Program, University Health Network, 200 Elizabeth Street, Toronto, ON M5G 2C4, Canada.

ORCID-Profile: Kristina M Blackmore

Förderung

  • Canadian Cancer Society
  • ICES

Zitieren

APA

Mittmann, N., Blackmore, K. M., Seung, S. J., Diong, C., Done, S. J., & Chiarelli, A. M. (2023). Healthcare and Cancer Treatment Costs of Breast Screening Outcomes among Higher than Average Risk Women. Current Oncology, 30(9), 8550-8562. https://doi.org/10.3390/curroncol30090620

Vancouver

Mittmann N, Blackmore KM, Seung SJ, Diong C, Done SJ, Chiarelli AM. Healthcare and Cancer Treatment Costs of Breast Screening Outcomes among Higher than Average Risk Women. Current Oncology. 2023;30(9):8550-8562. doi:10.3390/curroncol30090620

BibTeX
@article{Mittmann2023,
  author = {Mittmann, Nicole and Blackmore, Kristina M and Seung, Soo Jin and Diong, Christina and Done, Susan J and Chiarelli, Anna M},
  title = {Healthcare and Cancer Treatment Costs of Breast Screening Outcomes among Higher than Average Risk Women},
  journal = {Current Oncology},
  year = {2023},
  volume = {30},
  number = {9},
  pages = {8550--8562},
  doi = {10.3390/curroncol30090620}
}
Kostenlos starten →